ZA917149B - 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof - Google Patents

3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof

Info

Publication number
ZA917149B
ZA917149B ZA917149A ZA917149A ZA917149B ZA 917149 B ZA917149 B ZA 917149B ZA 917149 A ZA917149 A ZA 917149A ZA 917149 A ZA917149 A ZA 917149A ZA 917149 B ZA917149 B ZA 917149B
Authority
ZA
South Africa
Prior art keywords
aryl
pharmaceutical formulations
cck antagonists
quinazolinone
quinazolinone cck
Prior art date
Application number
ZA917149A
Other languages
English (en)
Inventor
Jefferson Ray Mccowan
Ray Mccowan Jefferson
Kenneth Jeff Thrasher
Jeff Thrasher Kenneth
Melvin Joseph Yu
Joseph Yu Melvin
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA917149B publication Critical patent/ZA917149B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA917149A 1990-09-13 1991-09-09 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof ZA917149B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/581,943 US5075313A (en) 1990-09-13 1990-09-13 3-aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof

Publications (1)

Publication Number Publication Date
ZA917149B true ZA917149B (en) 1992-05-27

Family

ID=24327210

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA917149A ZA917149B (en) 1990-09-13 1991-09-09 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof

Country Status (20)

Country Link
US (1) US5075313A (cs)
EP (1) EP0475755B1 (cs)
JP (1) JPH04247080A (cs)
KR (1) KR920006350A (cs)
CN (1) CN1059722A (cs)
AU (1) AU641043B2 (cs)
CA (1) CA2050994A1 (cs)
CZ (1) CZ279774B6 (cs)
DE (1) DE69113379T2 (cs)
ES (1) ES2078455T3 (cs)
FI (1) FI914262L (cs)
HU (1) HUT59128A (cs)
IE (1) IE913217A1 (cs)
IL (1) IL99402A0 (cs)
MX (1) MX9101035A (cs)
NO (1) NO913579L (cs)
NZ (1) NZ239712A (cs)
PT (1) PT98915A (cs)
YU (1) YU151691A (cs)
ZA (1) ZA917149B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340801A (en) * 1991-05-08 1994-08-23 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having cholecystokinin and gastrin antagonistic properties
US5204354A (en) * 1992-02-14 1993-04-20 Merck & Co., Inc. Substituted quinazolinones as neurotensin antagonists useful in the treatment of CNS disorders
ES2116411T3 (es) * 1992-06-05 1998-07-16 Merck Sharp & Dohme La sal sulfato de un triazol sustituido, composiciones farmaceuticas de la misma y su uso en terapia
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
GB0031315D0 (en) * 2000-12-21 2001-02-07 Glaxo Group Ltd Indole derivatives
PT1355644E (pt) 2001-01-26 2006-11-30 Schering Corp Utilização de compostos azetidinona substituídos para o tratamento de sitosterolemia
RS20100015A (sr) 2001-01-26 2010-12-31 Schering Corporation Kombinacija aktivatora receptora aktiviranog peroksizom- proliferatorom (ppar) fenofibrata sa inhibitorom apsorpcije sterola ezetimibom za vaskularne indikacije
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
EP1429756B1 (en) 2001-09-21 2006-11-22 Schering Corporation Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
JP2006508188A (ja) 2002-11-06 2006-03-09 シェーリング　コーポレイション 脱髄の処置のためのコレステロール吸収インヒビター
DE602004016123D1 (de) 2003-03-07 2008-10-09 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
CN1756756A (zh) 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
CN1756755A (zh) 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
KR101415503B1 (ko) * 2003-07-17 2014-07-04 플렉시콘, 인코퍼레이티드 Ｐｐａｒ 활성 화합물
US7348338B2 (en) * 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
GB0319126D0 (en) * 2003-08-14 2003-09-17 Smithkline Beecham Corp Chemical compounds
JP2008521831A (ja) * 2004-11-30 2008-06-26 プレキシコン，インコーポレーテッド Ｐｐａｒ活性化合物
US7531568B2 (en) * 2004-11-30 2009-05-12 Plexxikon, Inc. PPAR active compounds
AU2006287528A1 (en) * 2005-09-07 2007-03-15 Plexxikon, Inc. 1 , 4 and 1 , 5-disubstituted indole derivatives for use as PPAR active compounds
EP1940767A2 (en) * 2005-09-07 2008-07-09 Plexxikon, Inc. Pparactive compounds
EP1954283A2 (en) * 2005-11-04 2008-08-13 Hydra Biosciences, Inc. Compounds for modulating trpv3 function
PE20090159A1 (es) * 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
WO2021154966A1 (en) 2020-01-29 2021-08-05 Kamari Pharma Ltd. Compounds and compositions for use in treating skin disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192392A (en) * 1978-12-19 1983-02-15 M Ishikawa 3-(substituted (phenyl or pyridyl)) -3,4-dihydroquinazolin-4-ones
JPH03503650A (ja) * 1988-04-05 1991-08-15 アボツト・ラボラトリーズ Ｃｃｋアンタゴニストとしてのトリプトファン誘導体

Also Published As

Publication number Publication date
IL99402A0 (en) 1992-08-18
US5075313A (en) 1991-12-24
EP0475755A1 (en) 1992-03-18
DE69113379T2 (de) 1996-03-21
ES2078455T3 (es) 1995-12-16
MX9101035A (es) 1992-05-04
HUT59128A (en) 1992-04-28
NO913579L (no) 1992-03-16
EP0475755B1 (en) 1995-09-27
FI914262A0 (fi) 1991-09-10
AU8382991A (en) 1992-03-19
AU641043B2 (en) 1993-09-09
CA2050994A1 (en) 1992-03-14
NO913579D0 (no) 1991-09-11
DE69113379D1 (de) 1995-11-02
NZ239712A (en) 1993-06-25
IE913217A1 (en) 1992-02-25
KR920006350A (ko) 1992-04-27
CN1059722A (zh) 1992-03-25
HU912921D0 (en) 1992-01-28
FI914262A7 (fi) 1992-03-14
YU151691A (sh) 1994-01-20
CZ279774B6 (cs) 1995-06-14
FI914262L (fi) 1992-03-14
JPH04247080A (ja) 1992-09-03
CS279991A3 (en) 1992-04-15
PT98915A (pt) 1992-08-31

Similar Documents

Publication Publication Date Title
IL99402A0 (en) 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof
IL103621A0 (en) Endothelin receptor antagonists and pharmaceutical compositions containing them
NZ314184A (en) Substituted quinazoline derivatives and pharmaceutical compositions
EP0490806A3 (en) Nasal pharmaceutical compositions
NZ233320A (en) 3-substituted-2-oxo-indole derivatives and pharmaceutical compositions
NZ236625A (en) Pyrimidine derivatives and pharmaceutical compositions
EP0498268A3 (en) 5-oxo-l-proline derivatives and pharmaceutical use thereof
NZ221184A (en) Quinazoline derivatives and pharmaceutical compositions
IL112320A0 (en) Quinazoline-2,4- diones, their preparation and pharmaceutical compositions containing them
GB9217475D0 (en) Nauroprotective use cck antagonists
NZ233011A (en) Thieno-triazole-diazepine and pharmaceutical compositions
IL135723A (en) 1'-Ä4-Ä1-4-Fluorophenyl)-1H-indole-3-ylÜ-1-butylÜ-spiroÄisobenzofuran-1-(3H),4'-piperidineÜhydrohal ogenides and pharmaceutical compositions containing them
NZ243627A (en) 3-deoxy-mannosamine derivatives and pharmaceutical compositions thereof; intermediate precursors
IL105551A0 (en) Quinazolines and pharmaceutical compositions containing them
IL98785A0 (en) Pyrazolidinone cck and gastrin antagonists and pharmaceutical formulations thereof
NZ237484A (en) Xanthine derivatives and pharmaceutical compositions
NZ239483A (en) Phosphonopyrrolidine or -piperidine derivatives and pharmaceutical compositions
IL104944A0 (en) Anti-tumor agents and pharmaceutical compositions containing the same
NZ233121A (en) Substituted thiouracil derivatives and pharmaceutical compositions
ZA911065B (en) Chemical and pharmaceutical compositions
AP9000236A0 (en) Pharmaceutical formulations
NZ233940A (en) Cyclised n-oxo-tetrahydro-beta-carboline derivatives and pharmaceutical compositions thereof
NZ241331A (en) 3-phenyl-2-alkenamide derivatives and pharmaceutical compositions thereof
NZ236574A (en) Phenylsulphonamide derivatives and pharmaceutical compositions thereof
ZA917670B (en) Quinazoline derivatives and their preparation